Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-25-001147
Filing Date
2025-05-09
Accepted
2025-05-09 14:23:31
Documents
77
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20250331x10q.htm   iXBRL 10-Q 1532149
2 EX-31.1 tmb-20250331xex31d1.htm EX-31.1 9685
3 EX-31.2 tmb-20250331xex31d2.htm EX-31.2 10565
4 EX-32.1 tmb-20250331xex32d1.htm EX-32.1 5363
  Complete submission text file 0001410578-25-001147.txt   7345109

Data Files

Seq Description Document Type Size
5 EX-101.SCH tmb-20250331.xsd EX-101.SCH 65202
6 EX-101.CAL tmb-20250331_cal.xml EX-101.CAL 52830
7 EX-101.DEF tmb-20250331_def.xml EX-101.DEF 219119
8 EX-101.LAB tmb-20250331_lab.xml EX-101.LAB 437745
9 EX-101.PRE tmb-20250331_pre.xml EX-101.PRE 379946
80 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20250331x10q_htm.xml XML 1168029
Mailing Address 55 ADMINISTRATION ROAD, UNIT 13 VAUGHAN A6 L4K-4G9
Business Address 55 ADMINISTRATION ROAD, UNIT 13 VAUGHAN A6 L4K-4G9 905-541-3833
Target Group Inc. (Filer) CIK: 0001586554 (see all company filings)

EIN.: 463610035 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55066 | Film No.: 25929691
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)